Taken together, our data suggested that inhibiting autophagy using 36-077, a PIK3C3/VPS34 inhibitor, along with 5-FU treatment, has a profound effect on the GSK-3β/Wnt/β-catenin signaling to inhibit cancer stem cells. This evidence concerns the gene GSK3B and cancer.